𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical and functional outcomes of patients with schizophrenia treated with risperidone long-acting injection versus oral antipsychotics

✍ Scribed by J.M. Olivares; A. Rodriguez Morales; J. Diels; M. Povey; A. Lam; Z. Zhao


Book ID
118439656
Publisher
Elsevier Science
Year
2008
Tongue
French
Weight
62 KB
Volume
23
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Switching stable patients with schizophr
✍ Keith Lloyd; Muhammud A. Latif; Steve Simpson; Keshar L. Shrestha πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 2 views

## Abstract ## Objective This international, non‐randomised study evaluated maintained efficacy and safety of Risperidone Long‐Acting Injectable (RLAI) compared to previous medications. To investigate the possible effect of differences in national health care systems across Europe, the UK subset e

Effects of switching to long-acting inje
✍ Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Seung-Hyun Lee; Yo-Han Lee; Su-Jin Yang πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to long‐acting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirty‐six patients with schizophrenia treated with oral